✦ LIBER ✦

Baseline Characteristics of Patients with Refractory Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU) Enrolled in a Phase III, Randomized, Placebo-Controlled Trial of Omalizumab

✍ Scribed by Rosen, Karin; Hsieh, Hsin-Ju; Georgiou, Panayiotis; Casale, Thomas; Maurer, Marcus

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and Safety of Omalizumab in Chr

✍ Casale, Thomas; Maurer, Marcus; Hsieh, Hsin-Ju; Canvin, Janice; Saini, Sarbjit S 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 50 KB

A randomized, placebo-controlled, dose-r

✍ Saini, Sarbjit; Rosen, Karin E.; Hsieh, Hsin-Ju; Wong, Dennis A.; Conner, Edward 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 598 KB

Efficacy and Safety of Omalizumab in Pat

✍ Saini, Sarbjit S; Bindslev-Jensen, Carsten; Maurer, Marcus; Grob, Jean-Jacques; 📂 Article 📅 2015 🏛 Nature Publishing Group 🌐 English ⚖ 309 KB

Efficacy and safety of omalizumab in pat

✍ Saini, Sarbjit S. (author);Bindslev-Jensen, Carsten (author);Maurer, Marcus (aut 📂 Article 📅 2015 🏛 Nature Publishing Group 🌐 English ⚖ 309 KB

Correlations Between Changes in the Urti

✍ Stull, D.E.; McBride, D.; Balp, M.M.; Gnanasakthy, A. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

905 A Novel Gastrointestinal Prokinetic,

✍ Monica Palme; Peter G. Milner; Dave J. Ellis; Tonya Marmon; Daniel M. Canafax 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 64 KB